A Study of ELAPRASE in Treatment-na ïve Participants With Hunter Syndrome (Mucopolysaccharidosis [MPS] II)

Conditions:   Mucopolysaccharidosis (MPS);   Hunter Syndrome Interventions:   Drug: ELAPRASE;   Drug: Rituximab;   Drug: Methotrexate;   Drug: Intravenous Immunoglobulin (IVIG) Sponsors:   Takeda;   Takeda Development Center Americas, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials